JP2002544241A5 - - Google Patents

Download PDF

Info

Publication number
JP2002544241A5
JP2002544241A5 JP2000617930A JP2000617930A JP2002544241A5 JP 2002544241 A5 JP2002544241 A5 JP 2002544241A5 JP 2000617930 A JP2000617930 A JP 2000617930A JP 2000617930 A JP2000617930 A JP 2000617930A JP 2002544241 A5 JP2002544241 A5 JP 2002544241A5
Authority
JP
Japan
Prior art keywords
carbohydrate
active agent
carbohydrates
cells
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000617930A
Other languages
English (en)
Japanese (ja)
Other versions
JP4698843B2 (ja
JP2002544241A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/013260 external-priority patent/WO2000069470A2/en
Publication of JP2002544241A publication Critical patent/JP2002544241A/ja
Publication of JP2002544241A5 publication Critical patent/JP2002544241A5/ja
Application granted granted Critical
Publication of JP4698843B2 publication Critical patent/JP4698843B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000617930A 1999-05-17 2000-05-15 生体活性剤の改良された細胞取り込み Expired - Fee Related JP4698843B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13444299P 1999-05-17 1999-05-17
US60/134,442 1999-05-17
PCT/US2000/013260 WO2000069470A2 (en) 1999-05-17 2000-05-15 Improved cellular uptake of bioactive agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2004005518A Division JP5015411B2 (ja) 1999-05-17 2004-01-13 生体活性剤の改良された細胞取り込み

Publications (3)

Publication Number Publication Date
JP2002544241A JP2002544241A (ja) 2002-12-24
JP2002544241A5 true JP2002544241A5 (enExample) 2005-09-22
JP4698843B2 JP4698843B2 (ja) 2011-06-08

Family

ID=22463417

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000617930A Expired - Fee Related JP4698843B2 (ja) 1999-05-17 2000-05-15 生体活性剤の改良された細胞取り込み
JP2004005518A Expired - Fee Related JP5015411B2 (ja) 1999-05-17 2004-01-13 生体活性剤の改良された細胞取り込み

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2004005518A Expired - Fee Related JP5015411B2 (ja) 1999-05-17 2004-01-13 生体活性剤の改良された細胞取り込み

Country Status (6)

Country Link
US (4) US6734170B2 (enExample)
EP (1) EP1206283A2 (enExample)
JP (2) JP4698843B2 (enExample)
AU (1) AU779783B2 (enExample)
CA (1) CA2374003C (enExample)
WO (1) WO2000069470A2 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1206283A2 (en) * 1999-05-17 2002-05-22 Aesgen, Inc. Improved cellular uptake of bioactive agents
IT1318427B1 (it) * 2000-03-27 2003-08-25 A C R Applied Coating Res S A Gomma da masticare contenente composti aminoacidi solforati.
WO2004012662A2 (en) * 2002-08-01 2004-02-12 Aesgen, Inc. Improved treatment of cancer with glutamine
AU2003282619A1 (en) * 2002-10-11 2004-05-04 University Of Virginia Patent Foundation Use of stable glutamine derivatives to improve drug absorption
US20040265359A1 (en) * 2003-04-17 2004-12-30 Sacks Gordon S. Oral delivery formulations of L-glutamine
US7186517B2 (en) * 2003-08-01 2007-03-06 Aesgen, Inc. Compositions and methods for monitoring breast cancer treatment
KR20050104152A (ko) 2004-04-28 2005-11-02 최승호 경구용 약물의 흡수를 증진하는 약제학적 조성물
WO2005110046A2 (en) * 2004-05-10 2005-11-24 Aesgen, Inc. Method of enhancing uptake of keratinocyte growth factor
JP4804728B2 (ja) * 2004-07-23 2011-11-02 株式会社ファンケル Ｄｆａ含有経皮吸収促進剤
KR100699279B1 (ko) 2005-04-28 2007-03-23 학교법인 포항공과대학교 당 또는 당 유사체를 골격으로 하는 분자 수송체 및 그의제조방법
US7973084B2 (en) 2005-04-28 2011-07-05 Postech Academy-Industrial Foundation Molecular transporters based on alditol or inositol and processes for the preparation thereof
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
US20100168074A1 (en) * 2007-04-13 2010-07-01 Christopher Culligan Freezable Unit Dosage Delivery System and Method of Preparation
US20090011079A1 (en) * 2007-07-02 2009-01-08 Bestsweet, Inc. Hard Coated Confectionary Having A Consumable Soft Chewing Core With An Active And Method For Making Same
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
CA2702604C (en) 2008-09-22 2013-12-03 Biochemics, Inc. Transdermal drug delivery using an osmolyte and vasoactive agent
US8236768B2 (en) 2008-10-03 2012-08-07 3B Pharmaceuticals, Inc. Topical antiviral formulations
US12016950B2 (en) 2010-09-01 2024-06-25 Try This First, Inc. Devices and methods for treating ear pain
WO2012031123A2 (en) 2010-09-01 2012-03-08 Trythisfirst, Inc. Method of treating ear infections
AU2012242565B2 (en) 2011-04-13 2017-05-11 Thermolife International, Llc N-Acetyl Beta Alanine methods of use
WO2013133691A1 (en) * 2012-03-09 2013-09-12 N.V. Nutricia Liquid nutritional composition comprising free amino acids
US9849144B2 (en) 2013-09-16 2017-12-26 Healios Oncology Nutrition, LLC Glutamine and trehalose compositions
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US11052094B2 (en) 2015-05-29 2021-07-06 Sydnexis, Inc. D2O stabilized pharmaceutical formulations
US11154619B2 (en) 2017-02-17 2021-10-26 Creighton University Liposomal compositions with light illumination-induced drug release
JP2023505841A (ja) * 2019-12-16 2023-02-13 シドネキシス，インク． Ｄ２ｏを含む眼科用組成物
WO2022104157A1 (en) 2020-11-12 2022-05-19 Thermolife International, Llc Methods of increasing blood oxygen saturation
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
IL315206A (en) 2021-02-11 2024-10-01 Thermolife Int Llc A method of administering nitric oxide gas
TWI810852B (zh) 2022-03-18 2023-08-01 生展生物科技股份有限公司 凝結芽孢桿菌bc198或其代謝產物用於預防或輔助治療化療導致腸道受損相關病變或菌叢失衡之用途
CN119584988A (zh) * 2022-07-19 2025-03-07 成瘾与精神健康中心 氨基酸口服液组合物

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058942A (en) * 1958-07-07 1962-10-16 Standard Oil Company Of Chicag Polyvinyl chloride homogenized with triisobutyl trimesate and method of preparation
US3085942A (en) * 1960-12-28 1963-04-16 Hoffmann La Roche Antitussive compositions and preparation
US3957964A (en) * 1974-01-30 1976-05-18 Colgate-Palmolive Company Dentifrice containing encapsulated flavoring
US4071614A (en) * 1975-06-03 1978-01-31 Colgate Palmolive Company Dentifrice containing encapsulated flavoring
US4348378A (en) * 1979-08-09 1982-09-07 Kosti Carl M Plaque disclosing dentifrice compositions with semi-solid microcapsules of dye
JPS6030650B2 (ja) * 1979-10-26 1985-07-17 日本油脂株式会社 座薬基剤組成物
US4352825A (en) * 1981-02-23 1982-10-05 Nabisco Brands, Inc. Coextruded chewing gum containing a soft core portion
US4352823A (en) * 1981-04-13 1982-10-05 Nabisco Brands, Inc. Coextruded chewing gum containing a soft non-SBR gum core portion
US4439194A (en) * 1981-09-08 1984-03-27 Merck & Co., Inc. Water and drug delivery system for suppository use
US4559157A (en) * 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
US4647459A (en) * 1983-07-20 1987-03-03 Warner-Lambert Company Confectionery compositions containing magnesium trisilicate adsorbates
LU84979A1 (fr) * 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4885173A (en) * 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
US5763485A (en) 1985-09-12 1998-06-09 Brigham And Women's Hospital Method of treating catabolic, gut-associated pathological processes and impaired host defenses
US5397803A (en) 1985-09-12 1995-03-14 Brigham And Women's Hospital Use of glutamine to reduce rate of pathogenic microorganism infection
US5684045A (en) 1985-09-12 1997-11-04 Brigham And Women's Hospital Method of treating pancreatic atrophy
DE3601398A1 (de) * 1986-01-18 1987-07-23 Fresenius Ag Verwendung von oligopeptiden zur behandlung von cerebralen stoerungen
US4983595A (en) * 1986-05-22 1991-01-08 Syntex (U.S.A.) Inc. Aqueous steroid formulations for nasal administration
US4820508A (en) * 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US5744166A (en) * 1989-02-25 1998-04-28 Danbiosyst Uk Limited Drug delivery compositions
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US5160331A (en) * 1991-07-12 1992-11-03 Progeny Products, Inc. Absorbent insert
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
US5438075A (en) * 1993-03-30 1995-08-01 Skubitz; Keith M. Oral glutamine to reduce stomatitis
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
US5726146A (en) * 1994-12-06 1998-03-10 Natural Supplement Association, Incorporated Non-steroidal, anabolic dietary supplement and method to increase lean mass without linked increase fat mass
US5569466A (en) * 1995-05-17 1996-10-29 R. P. Scherer Corporation Fill compositions for soft elastic gel capsules
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
WO1997014310A1 (en) * 1995-10-13 1997-04-24 Novo Nordisk A/S Fungicidal carbohydrate preparations
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
KR100611516B1 (ko) * 1996-01-12 2007-04-25 테이코쿠메딕스 가부시키가이샤 젤리상경구의약조성물
US5716959A (en) * 1996-02-13 1998-02-10 T. Ronald Theodore Method of treating disease with piperazine zwitterion compounds
US5891467A (en) * 1997-01-31 1999-04-06 Depotech Corporation Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
US5849335A (en) * 1997-06-02 1998-12-15 Nestec S.A. Composition and method for providing glutamine
JPH11302200A (ja) * 1998-04-15 1999-11-02 Sumitomo Pharmaceut Co Ltd 崩壊性の改善されたｌ−グルタミン及びメタケイ酸アルミン酸マグネシウム含有製剤
JP4231940B2 (ja) * 1998-04-15 2009-03-04 大日本除蟲菊株式会社 ゲファルナート及びｌ−グルタミン含有製剤
JP4423682B2 (ja) * 1998-04-20 2010-03-03 味の素株式会社 輸液用グルタミン凍結乾燥物の調製法
US6159492A (en) * 1999-03-04 2000-12-12 Manzone; Cheryl Drug storage and delivery system containing a medicated lollipop
EP1206283A2 (en) * 1999-05-17 2002-05-22 Aesgen, Inc. Improved cellular uptake of bioactive agents
US6391332B1 (en) * 2000-04-20 2002-05-21 Baxter International, Inc. Therapeutic micronutrient composition for severe trauma, burns and critical illness
US6479068B1 (en) * 2000-06-30 2002-11-12 Baxter International Inc. Therapeutic nutrient regimen for alleviating mucositis, stomatitis and cachexia in oncology patients
ATE410459T1 (de) * 2002-01-14 2008-10-15 Gen Hospital Corp Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung
WO2004012662A2 (en) * 2002-08-01 2004-02-12 Aesgen, Inc. Improved treatment of cancer with glutamine
US20040265359A1 (en) * 2003-04-17 2004-12-30 Sacks Gordon S. Oral delivery formulations of L-glutamine

Similar Documents

Publication Publication Date Title
JP2002544241A5 (enExample)
Shaikh et al. Mucoadhesive drug delivery systems
US5661130A (en) Absorption enhancers for drug administration
JP4698843B2 (ja) 生体活性剤の改良された細胞取り込み
RU2428987C2 (ru) Нейрозащитное действие растворимой урсодезоксихолевой кислоты в моделях фокальной ишемии
ES2326209T3 (es) Produccion de microesferas.
CN105288648B (zh) 一种亲水性药物的磷脂化合物、其药物组合物及应用
EP1494630A2 (en) Bioadhesive drug delivery system
ES2909043T3 (es) Composiciones de zinc para sistemas de microagujas recubiertos
JP4971160B2 (ja) 安定するｐｅｇ化インターフェロン処方物
US20040258663A1 (en) Compositions and methods for enhanced mucosal delivery of interferon alpha
KR920703066A (ko) 경구용 혈당강하제인 글리피자이드의 투여를 위한 제형
JP2012246312A (ja) 炭水化物、脂質、またはアミノ酸キャリアを含むγ−ヒドロキシブチレート組成物
Chand et al. In situ gel: A Review
CN108434125A (zh) 一种介孔二氧化硅-胰岛素纳米缓释经皮贴剂的制备方法
KR20080063401A (ko) 위장 장애를 위한 담즙 제제
KR20130009647A (ko) 젤리 형상 제제 및 젤리 형상 제제의 제조 방법
EP3634507B1 (en) Oral prolonged drug delivery platforms
US20110150976A1 (en) Transdermal delivery of oligosaccharides
ES2314738T3 (es) Composicion bioadhesiva con liberacion programada.
CA2617370A1 (en) Improved cellular uptake of bioactive agents
ES2279707B1 (es) Formulaciones orales que comprenden 3'-azidonucleosidos.
CN103957890B (zh) 一种无针注射用注射剂的制备方法及应用
AU2012200105B2 (en) Bioadhesive composition with programmed release
KR20240002285A (ko) 인플루엔자 백신을 포함하는 마이크로니들 및 이를 포함하는 인플루엔자 백신 패치